6:24 PM
 | 
Dec 20, 2013
 |  BC Extra  |  Company News

No CHMP recommendation yet on Teva's laquinimod

Active Biotech AB (SSE:ACTI) said partner Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) was notified by EMA's CHMP that the committee has not reached a decision on an...

Read the full 118 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >